Vexpra
Vexpra Genomic-Driven Drug Discovery Platform, (VGADDAI ) using AI methods and technologies, designs antibodies based on three alternative and complementary models
Vexpra
- Category: Therapeutics
VGADDAI machine-learning algorithms highlight problem areas in antibodies that make them prone to binding non-target molecules.
VGADDAI models pinpoint the positions in antibodies that are causing trouble and change those positions to correct the problem without causing new ones, bind tightly to what they’re supposed to, repel each other and ignore other things in the body
VGADDAI Platform
ML Algorithms
Other Projects
